Literature DB >> 12467732

Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.

M Orth1, R R Mundegar.   

Abstract

Membrane bound glycogen storage in muscle is characteristic for the lysosomal storage disorder acid maltase (acid alpha-glucosidase) deficiency while in phosphofructokinase and phosphorylase deficiency, glycogen is stored free in the cytoplasm. Using immunohistochemistry, we examined whether acid maltase deficiency had an effect on early endosomes, recycling endosomes and trans-Golgi network, vesicle systems linked to lysosomes. Vacuolated glycogen containing fibres stained intensely for the lysosomal marker lysosomal-membrane-protein-1 within fibres and at the sarcolemma. There was a similar increase in immunoreactivity for markers of early endosomes (rab5), recycling endosomes (transferrin receptor) and the trans-Golgi network. In acid maltase deficiency, but not in normal muscle or other glycogenoses, staining for the insulin responsive glucose transporter 4 was markedly increased and partially co-localised with all vesicular markers. Our results suggest an effect of acid maltase deficiency extending to various vesicle systems linked to lysosomes. The enzyme defect may also affect the homoeostasis of receptors cycling through these organelles such as glucose transporter 4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12467732     DOI: 10.1016/s0960-8966(02)00186-4

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

Review 1.  Acid alpha-glucosidase deficiency (Pompe disease).

Authors:  Tokiko Fukuda; Ashley Roberts; Paul H Plotz; Nina Raben
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 2.  Pompe disease: literature review and case series.

Authors:  Majed Dasouki; Omar Jawdat; Osama Almadhoun; Mamatha Pasnoor; April L McVey; Ahmad Abuzinadah; Laura Herbelin; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 3.  Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.

Authors:  Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

4.  2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease.

Authors:  U Plöckinger; V Prasad; A Ziagaki; N Tiling; A Poellinger
Journal:  Hum Genomics       Date:  2018-03-09       Impact factor: 4.639

5.  Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease.

Authors:  Kristin M Taylor; Elizabeth Meyers; Michael Phipps; Priya S Kishnani; Seng H Cheng; Ronald K Scheule; Rodney J Moreland
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.